Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_assertion type Assertion NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_head.
- NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_provenance.
- NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_assertion evidence source_evidence_literature NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_provenance.
- NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_assertion SIO_000772 12835728 NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_provenance.
- NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_assertion wasDerivedFrom befree-20140225 NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_provenance.
- NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_assertion wasGeneratedBy ECO_0000203 NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_provenance.